BIOMAT Database Logo BIOMAT Database Logo

Effects of lipopolysaccharide on interleukin-6 production in perfused human placental cotyledons. 2000

R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
Department of Obstetrics and Gynecology, Madigan Army Medical Center, Tacoma, Washington, USA. MajWagner@aol.com

OBJECTIVE To determine if lipopolysaccharide (LPS) alters production of interleukin-6 (IL-6) or vascular tone in perfused placental cotyledons. METHODS Control and study cotyledons from nine placentas were perfused for 3 h. Study cotyledons received LPS in concentrations of 0.01 mcg/ml (n = 3), 0.1 mcg/ml (n = 3), or 1.0 mcg/ml (n = 3). Effluents were collected at 30, 60, 120, and 180 min following infusion with LPS. IL-6 concentrations were measured by enzyme-linked immunosorbant assay. Perfusion pressures were recorded at 10-min intervals. Data were analyzed using ANOVA for repeated measures. RESULTS IL-6 production significantly increased over time in both the study and control cotyledons (P = 0.002). LPS treatment did not affect IL-6 production (P = 0.85) and there were no observable dose effects (P = 0.13). Perfusion pressures did not differ (P = 0.16). CONCLUSIONS The isolated perfused placental cotyledon produces IL-6 and concentrations increase over time. LPS does not alter production of IL-6 or fetoplacental vascular tone.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
Hypoxia-induced fetoplacental vasoconstriction in perfused human placental cotyledons.
November 1987, American journal of obstetrics and gynecology,
R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
Effects of lipopolysaccharide on human placental prostaglandin F2 alpha production in vitro.
June 1994, Prostaglandins, leukotrienes, and essential fatty acids,
R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
Direct and indirect effects of Porphyromonas gingivalis lipopolysaccharide on interleukin-6 production by human gingival fibroblasts.
August 1992, Oral microbiology and immunology,
R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
L-arginine prevents hypoxia-induced vasoconstriction in dual-perfused human placental cotyledons.
November 2015, Placenta,
R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
Insulin effect on interleukin 1 (IL-1) and interleukin 6 (IL-6) production by lipopolysaccharide-stimulated human monocytes.
February 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
Stimulation of interleukin-1beta-independent interleukin-6 production in human dental pulp cells by lipopolysaccharide.
December 1996, Biochemical and molecular medicine,
R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
Effects of lipopolysaccharide on production of interleukin-1 and interleukin-6 by bovine mammary epithelial cells in vitro.
January 1999, The Journal of veterinary medical science,
R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
The impact of interleukin-6 promoter -597/-572/-174genotype on interleukin-6 production after lipopolysaccharide stimulation.
February 2007, Clinical and experimental immunology,
R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
Effect of lipopolysaccharide and inflammatory cytokines on interleukin-6 production by healthy human gingival fibroblasts.
February 1998, Infection and immunity,
R K Wagner, and R M Hinson, and C C Apodaca, and N Hoeldtke, and T Buchanan, and R F Hume, and B C Calhoun
Effects of interferons on the production of interleukin-6 and interleukin-8 in human keratinocytes.
June 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Copied contents to your clipboard!